SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009117
Filing Date
2024-03-25
Accepted
2024-03-25 07:30:35
Documents
18
Period of Report
2024-03-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240324_8k.htm   iXBRL 8-K 49825
2 EXHIBIT 4.2 ex_644165.htm EX-4.2 103237
3 EXHIBIT 4.3 ex_644166.htm EX-4.3 51079
4 EXHIBIT 10.3 ex_644163.htm EX-10.3 77152
5 EXHIBIT 10.4 ex_644164.htm EX-10.4 18108
  Complete submission text file 0001437749-24-009117.txt   497007

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20240324.xsd EX-101.SCH 3401
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240324_def.xml EX-101.DEF 11421
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240324_lab.xml EX-101.LAB 15310
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240324_pre.xml EX-101.PRE 11581
21 EXTRACTED XBRL INSTANCE DOCUMENT nby20240324_8k_htm.xml XML 2850
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 24776889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)